(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Travel Through France's Most Iconic Wine Regions By Train On An Immersive Seven-Day Journey - 2Under pressure at home, Belgium's leader treads a tight rope with EU partners over funds for Ukraine
- 3People Are Sharing The One Picture They Can't See Without Laughing, And It's The Comedy Spiral You Need Today
- 4Best Wellness Tracker Keep You On target
- 5The Best Internet Mastering Stages for Expertise Improvement
- Accomplishing Balance between fun and serious activities: Procedures for a Better Life
- Are your hormones imbalanced? Doctors explain how to know if you need testing
- AI is making spacecraft propulsion more efficient – and could even lead to nuclear-powered rockets
- Floods, Landslides Triggered By Heavy Rain In Afghanistan Leave 77 Dead In 10 days, Authorities Say
- Bismuth’s haredi draft bill won’t change enlistment, IDI expert tells 'Post'
- Trump says Venezuela will start 'turning over' oil to the U.S. Is that the reason he toppled Maduro — or is it something else?
- Online business Stages for Little Retailers
- Sound Propensities: 20 Methods for helping Your Insusceptible Framework
- Hand Skin Is Additionally Significant - What You Ought to Realize About Hand Cream
